Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

TCS building AI platform to accelerate drug discovery, clinical trials in India

17 August 2026 · By · Wire by Fusion42

Published

17 August 2026

Topic

opportunities

◆ Sectors

Biotech

◆ Geography

India

◆ Source

Read at indiatoday.in →

◆ Verified

Fusion42 · 17 August 2026 · Fusion42 review

TCS has launched the ADD AgentHub, an AI platform to help pharmaceutical companies in India accelerate drug development, clinical trials, and drug safety management by automating repetitive tasks while maintaining regulatory compliance and human oversight.

This Wire brief sits within Fusion42's coverage of Biotech, and 3 sources have reported it between 17 Aug 2026 and 19 Aug 2026.

◆ ◆ The Wire takeaway

Pharma founders can now hand repetitive clinical trial tasks to AI while keeping control of critical decisions, freeing their teams to focus on innovation and oversight.

◆ Coverage

3 sources · first reported 17 Aug 2026 · latest 19 Aug 2026

◆ Related on Wire

◆ Topics

Biotechai-platformpharmaceuticalsclinical-trialsdrug-discoveryregulatory-compliance